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Objectives: saphenous vein injury is believed to predispose to vein graft stenoses. The aims of this study were to assess
the endothelial injury associated with infrainguinal vein bypass surgery by serial measurements of serum thrombomodulin
concentration as well as by platelet scintigraphy, and to relate these findings with the postoperative development of
stenoses.
Methods: in 35 patients undergoing vein bypass surgery serum thrombomodulin concentration was measured pre- and
postoperatively. Autologous 111-indium labelled platelets were administered into the common femoral artery immediately
after restoration of flow in the graft and scintigraphic images were obtained 4 and/or 24 h later.
Results: serum thrombomodulin increased markedly from median 17 ng/ml preoperatively to 32 ng/ml 1 day after surgery
(p=0.00002). Platelet scintigraphy revealed a total of 62 focal activity accumulations, the majority being located in the
anastomotic regions. Among the 30 patients with grafts remaining patent at 30 days stenoses occurred in nine (16%) of
55 regions with scintigraphic platelet accumulations as compared to only four (4%) of 94 regions without platelet
accumulations (p=0.03).
Conclusions: the very high predictive value of a negative platelet scintigraphy (96%) strongly suggests that localised
perioperative endothelial injury is an important pathogenetic factor in the development of vein graft stenoses.
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Introduction surgery was assessed by serial measurements of
plasma thrombomodulin levels and by early post-
Within one year after surgery approximately a quarter operative indium-111 platelet scintigraphy. The throm-
bomodulin levels and the scintigraphic findings wereof infrainguinal vein bypasses develop stenoses that,
uncorrected, may progress to occlusion.1–3 Vein graft related to the postoperative development of stenoses
during follow-up.stenoses are assumed to result from intraoperative
damage of the saphenous vein leading to intimal hy-
perplasia and subsequently luminal narrowing.4–6
However, a causal relationship between such injury Materials and Methods
and stenoses has not been established. Thrombo-
modulin is a glycoprotein receptor expressed on the Subjects
surface of endothelial cells and released into the cir-
culation in response to injury. An increased serum Forty patients scheduled for infrainguinal vein bypass
level of thrombomodulin is a reliable marker of endo- surgery between January 1994 and June 1996 were
thelial cell damage.7–11 Platelets aggregate on damaged included in the study. Although preoperative vein
endothelium and play a central role in vascular repair. evaluation was performed by B-mode ultrasound
Previously, early postoperative platelet scintigraphy imaging five patients were intra-operatively found
has been shown to be valuable in the detection of focal to have poor quality veins. In these a poly-
endothelial injury in patients undergoing vascular sur- tetrafluoroethylene (PTFE) bypass was inserted and
gery.12–15 In this study vein graft injury during bypass they were excluded from further analysis. The median
age of the remaining 19 males and 16 females was 72
(range 44–82) years. Six patients were diabetic and∗ Please address all correspondence to: T. Nielsen, Hostrups Have
13, 2.th, DK-1954 Frederiksberg C, Denmark. seven received acetylsalicylic acid preoperatively. The
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indication for surgery was intermittent claudication in were washed again and incubated with the substrate
solution. After color stabilisation the optical densitysix, rest pain in nine and ischaemic ulceration or
gangrene in 20 patients. The study was approved by was measured by an automated ELISA-plate reader
with the suggested filters (Titertek Multiscan Plusthe local Research Ethics Committee and informed
consent was obtained in each case. MKII, ICN/Flow, Meckenheim, Germany). The con-
centrations of the samples were calculated in relation
to the respective reference standard curve. The mean
of duplicates was used for further analysis.Surgery
An in situ vein bypass was performed in 34 patients
and a composite vein graft in one patient. The level
of the proximal anastomosis was the femoral artery
Platelet scintigraphyin 34 and the popliteal artery in one. The level of the
distal anastomosis was the popliteal artery above the Preoperatively a blood sample was drawn withoutknee in one case, the popliteal artery below the knee venous stasis. The platelets were isolated and labelledin 15 patients, a single crural artery in 17 and a pedal with indium-111 as previously described.12,20 Followingartery in two patients. The surgical procedures were meticulous haemostasis and immediately after res-carried out as described by Leather et al.16 The proximal toration of flow in the graft the labelled plateletsvein was separated from the common femoral vein were re-injected into the femoral artery just above theand the most proximal valves were excised under proximal anastomosis. Gamma camera images of thedirect vision. A Fogarthy embolectomy catheter was thigh and leg in the antero-posterior projection wereintroduced from the distal end and an intraluminal obtained 4 h (n=3), 24 h (n=23) or 4 and 24 h (n=9)valve cutter was attached to it. These were drawn after platelet injection using a GE XRT camera togetherdistally with the vein distended by a papaverine/ with a Starcam computer. The scintigraphic studiesheparin/saline solution infused at a pressure of were evaluated by two experienced examiners who200–300 mmHg. After completion of the proximal ana- were blinded with respect to clinical outcome. Focalstomosis arteriovenous fistulas were identified by platelet accumulations were observed in the followingflowmetry and ligated. During arterial clamping intra- areas: the groin, the proximal and distal parts of thevenous heparin (50 i.u. kg−1 body weight) was given thigh, the knee, the proximal and distal parts of thefor thrombosis prophylaxis. From the day before sur- leg and the foot. The number of regions assessed ingery until mobilisation all patients received sub- each patient varied from four to six according to thecutaneous low molecular weight heparin (logiparin level of the proximal and distal anastomoses. The3500 i.u. daily) and after mobilisation acetylsalicylic length of the activity accumulations were measuredacid 500 mg a day. and the intensity was semiquantified as moderate or
intense.
Thrombomodulin assays
Blood samples for thrombomodulin assays were
drawn preoperatively, 4 h, 1 and 2 days post- Follow-up
operatively. Aliquots of the sera had been stored at
−20 °C until analysed. The serum thrombomodulin After discharge the patients were included in a follow-
up regimen consisting of ankle blood pressure meas-levels were determined by commercially available 2-
site enzyme-linked immunosorbent assays (ELISA) urements by Doppler technique and ultrasound duplex
scanning at 6 weeks, 3, 6, 9 and 12 months. A localised(Diagnostica Stago, Asnie`res, France, distributed by
Boehringer Mannheim GmbH, Mannheim, Germany) increase in the peak systolic velocity exceeding 250%
was taken as an indicator for a significant stenosis.as described earlier.17–19 Briefly, according to the manu-
facturer’s instruction, precoated 96-well microtitre Reintervention was considered in patients with sten-
oses associated with an interval reduction in the ankleplates were incubated with diluted samples (serum-
dilution: 1:5) or serial dilutions of the provided stand- brachial index of more than 0.15.
The occurrence of bypass occlusions and of stenosesard. After washing the ELISA-plates were incubated
with the secondary HRP-conjugated monoclonal anti- during follow-up were related to thrombomodulin
levels and scintigraphic findings.thrombomodulin-antibody. Subsequently, the plates
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Fig. 1. Serum thrombomodulin levels measured preoperatively, 4 h,
1 and 2 days after infrainguinal vein bypass surgery in 26 patients
(median values and inter-quartile ranges. ∗: p<0.001 compared with
preoperative values (Wilcoxon test).
Statistics
Fig. 2. Scintigraphic study of an in situ vein graft obtained in
the anteroposterior projection 4 h after intraarterial injection of
Frequencies were compared by Fisher’s exact test. autologous 111-indium labelled platelets showing a moderate ac-
tivity accumulation at the proximal anastomosis, three moderateSince most of the data was not normally distributed,
activity accumulations in the body of the graft and an intenseresults are mainly presented as median values with activity accumulation at the distal anastomosis (upper left image:
ranges, and non-parametric statistics were used for thigh, right image: knee region, bottom image: leg).
comparisons: the Mann–Whitney test for comparison
of continuous variables between groups and the Wil-
coxon test for comparison of continuous variables Scintigraphic findings
within groups.
A total of 62 focal platelet accumulations were iden-
tified in the groin (n=27), proximal thigh (n=13),
distal thigh (n=5), knee region (n=2), proximal legResults
(n=10) and distal leg (n=5). The activity ac-
cumulations measured median 5 (range 1–25) cm inThrombomodulin assays
length and were graded as moderate in 46 cases and
intense in 16 cases (Fig. 2).For various logistical reasons blood samples for throm-
bomodulin assay were not obtained in six patients. In
three patients a very high serum thrombomodulin
level (>70 ng/ml) was observed preoperatively and
Clinical findingsthese were not included in further analyses. One of
the three patients had non-insulin dependent diabetes
Early (<30 days) eventscomplicated by end stage renal disease. In the other
Five (14%) bypasses, including the composite veintwo cases no cause of the elevated preoperative throm-
graft, thrombosed within 30 days after surgery.bomodulin level could be identified. Serum thrombo-
modulin in the remaining 26 patients increased
significantly from 17 (range 10–60) ng/ml pre- Events during follow-up
The thirty patients with in situ vein grafts whichoperatively, to 21 (range 12–59) ng/ml 4 h, p=0.0005,
32 (range 16–59) ng/ml 1 day, p=0.00002 and 31 (range remained patent at 30 days were followed a median of
12 (range 1–18) months. Nine non-haemodynamically14–55) ng/ml 2 days, p=0.00007 after vein bypass
surgery (Fig. 1). The median increase in thrombo- significant stenoses and three haemodynamically sig-
nificant stenoses were identified in nine grafts a me-modulin from preoperatively to 4 h postoperatively
was 3.0 (range 2–19) ng/ml and from preoperatively dian of five (range 1–9) months after surgery. The
stenoses were located in the groin in seven, proximalto day 1 15.5 (range 1–42) ng/ml. Neither the pre-
operative thombomodulin levels nor the postoperative leg in one, distal leg in three and a long stenosis
extended over both the proximal and the distal leg.increase differed significantly between diabetics and
non-diabetics. Two stenotic grafts were revised and remained patent
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Table 1. Serum thrombomodulin levels (ng/ml) measured pre- preparation of the saphenous vein for in situ vein
operatively, 4 h, 1 and 2 days after infrainguinal vein bypass
bypass surgery causes extensive morphological andsurgery in the subgroup of 22 patients with vein grafts remaining
patent during the first 30 days postoperatively. The patients are functional endothelial damage.21–24 However, the
classified according to the presence or absence of bypass stenosis pathogenetic significance of this perioperative injury
(median values and ranges).
in the development of intimal hyperplasia is unknown.
Absence of Presence of p Only one clinical study has addressed the issue in
stenosis (n=16) stenosis (n=6) humans. Moody et al.25 peroperatively recorded events
assumed to lead to endothelial damage such as fistulaPreoperatively 19 (10–60) 17 (15–41) n.s.
4 h after surgery 22 (12–59) 18 (15–41) n.s. ligation, valve disruption and clamping. It was found
Day 1 34 (16–59) 38 (19–52) n.s. that these events showed no correlation with sub-Day 2 32 (14–55) 36 (15–43) n.s.
sequent stenoses in in situ vein grafts. However, no
direct assessment of the endothelial state was per-
throughout the rest of follow-up. Of the seven con- formed.
servatively treated grafts with stenoses one occluded Thrombomodulin is the transmembranous glyco-
12 months after surgery. protein receptor for thrombin mainly expressed on
endothelial cells. The thrombomodulin-thrombin com-
plex acts as an important anticoagulant resulting in
accelerated activation of protein C.26–28 These functionsCorrelation between events and thrombomodulin levels
contribute to the non-thrombogenic nature of endo-
thelium. In-vitro studies have confirmed that solubleThere was no difference in preoperative or post-
thrombomodulin is a reliable marker of endothelial celloperative serum thrombomodulin levels between
damage independent of physiological activation.7–11patients with grafts occluding early and patients with
grafts remaining patent at 30 days. Among the patients Thrombomodulin activity is present in veins harvested
with grafts which remained patent at 30 days serum for coronary artery bypass grafting but greatly reduced
thrombomodulin levels preoperatively to 2 days post- in mechanically denuded vein segments29,30 and in
operatively were similar in those who developed graft veins exposed to arterial flow.31 This reduced thrombo-
stenoses and those who did not develop stenoses modulin activity may result in dysfunctional endo-
(Table 1). thelial anticoagulant activity and possibly contributes
to graft thrombosis.
In the present study a marked increase in serum
thrombomodulin was observed in the first 2 daysCorrelation between events and scintigraphic activity
following vein bypass surgery. The initial (within 4 h)accumulations
increase is due to the direct, surgery dependent endo-
thelial damage within the vein in addition to theNo difference in the number or intensity of activity
general response to surgery. The further increase inaccumulations between patients with grafts occluding
thrombomodulin observed between 4 h and 1 day afterearly and patients with grafts remaining patent at 30
surgery reflects the pathophysiological process of thedays was observed. Among the 30 grafts which were
removal from intraoperatively injured cells resultingpatent at 30 days stenoses were identified in nine
in a time-dependent release of thrombomodulin.32 The(16%) of 55 regions where activity accumulations had
been visualised as compared to only four (4%) of 94 haemodynamic changes with increased pressure and
regions where no activity accumulations had been flow rate in the vein graft after bypass surgery might
observed, p=0.03 (Tables 2 and 3). The occurrence of contribute, together with the perioperative endothelial
stenoses showed no correlation with length or intensity damage, to this prolonged release of thrombomodulin.
of the activity accumulations. The diagnostic ac- In keeping with our results plasma thrombomodulin
curacies of perioperative scintigraphy in predicting has been found to increase after other cardiovascular
the development of postoperative graft stenoses are procedures, including percutaneous transluminal an-
listed in Table 3. gioplasty and open heart surgery.33–36 On day 2 the
thrombomodulin values showed a tendency to de-
crease. Changes beyond 2 days postoperatively were
not assessed in the present study but in animal ex-Discussion
periments the endothelial thrombomodulin activity
has been found to return to normal 1 week afterGraft stenoses due to intimal hyperplasia are the major
cause of infrainguinal vein bypass failure. Surgical balloon catheter denudation.30 The association between
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Table 2. The occurrence of graft stenoses according to focal scintigraphic platelet accumulations in 30 patients
with vein grafts remaining patent at 30 days. The varying number of segments is due to the variable length
of the vein grafts.
Region n Platelet Stenosis No platelet Stenosis p
accumulation accumulation
Groin 29 25 6 (24%) 4 1 (25%) n.s.
Proximal thigh 29 11 0 (0%) 18 0 (0%) n.s.
Distal thigh 29 5 0 (0%) 24 0 (0%) n.s.
Knee 30 1 0 (0%) 29 0 (0%) n.s.
Proximal leg 17 10 0 (0%) 7 2 (29%) n.s.
Distal leg 13 3 3 (100%) 10 1 (10%) n.s.
Foot 2 0 0 (0%) 2 0 (0%) n.s.
Total 149 55 9 (16%) 94 4 (4%) 0.03
Table 3. Occurrence of graft stenoses according to the presence or 24 h postoperatively and a pilot study has dem-
absence of focal scintgraphic platelet accumulations in 149 vein
onstrated that scingraphic findings do not changegraft segments.
significantly during that period.12 Since the purpose
Clinical outcome n Platelet No platelet of the scintigraphic studies was to identify the presence
accumulation accumulation
of localised platelet accumulations an assessment of the
Stenosis 13 9 4 overall activity in the vein grafts was not performed. As
No stenosis 136 46 90 previously described,12 we found platelet aggregations,
Total 149 55 94 mainly located in the regions of anastomosis, in the
majority of patients undergoing vein bypass surgery.Diagnostic accuracy of perioperative platelet scintigraphy in
Extravascular accumulations due to intraoperativepredicting postoperative development of graft stenoses.
bleeding are unlikely as meticulous haemostasis was
Positive predictive value 16% (9/55) performed in all cases. Furthermore, using 111-indiumNegative predictive value 96% (90/94)
labelled platelets Stratton et al.13 showed that non-Sensitivity 69% (9/13)
Specificity 66% (90/136) vascular surgery does not lead to platelet ac-
Overall accuracy 66% (99/149)
cumulations. It therefore seems justified to assume
that the platelet accumulations are intraluminal and
represent perioperative endothelial injury.soluble thrombomodulin and atherosclerosis remains
The observed lack of association between plateletcontroversial.37 Though more research is needed to
accumulations and early postoperative occlusions sug-clarify the issue our finding that pre- and postoperative
gest that endothelial injury does not play a centralthrombomodulin levels did not differ between patients
role in these events. In patients with grafts remainingwho developed graft stenoses and patients who did
patent at 30 days the occurrence of vein graft stenosesnot develop stenoses does not support the assumption
was four times higher in regions where platelet ag-that thrombomodulin is involved in the pathogenesis
gregations had been identified as compared to regionsof vein graft stenoses.
without platelet aggregations. Only in four cases, outPlatelets play a key role in the repair of vascular
of a total of 149 regions without visible platelet binding,injuries. Immediately after an injury platelets ag-
a stenosis complicated the following 12 months. Thegregate on the luminal surface and may form throm-
very high predictive value (96%) of a negative scin-bosis. Various factors secreted from activated platelets
tigraphy strongly suggests that localised perioperativeas well as from damaged endothelial cells stimulate
endothelial injury, as demonstrated by platelet ac-the proliferation of smooth muscle cells and synthesis
cumulation at the site of subsequent development ofof extracellular matrix leading to intimal thickening.4,6
stenosis, is an important pathogenetic factor. The lowPlatelet scintigraphy has proven an effective tool in
positive predictive value shows that, in spite of endo-in vivo studies of vascular injury in humans.12–15,38–40 In
thelial injury in many patients, the bypass may remainthe present study the labelled platelets were injected
patent without development of a clinically significantdirectly into the inflow artery in order to improve
stenosis, confirming previous observations that ad-image quality by increasing the amount of labelled
ditional factors are involved. Among these preexistingthrombocytes to the region of interest. Intravenous
morphological changes in the saphenous vein41,42 asadministration of labelled platelets might lead to their
well as serological risk factors, including high plasmasequestration in the spleen and bone marrow. The
time of scintigraphic assessment varied between 4 and levels of fibrinogen and the presence of antibodies to
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